Economic Burden Of RSV Among High-Risk Adults Is Substantial, Study Indicates

December 28, 2023

Infectious Disease Advisor (12/27, Kuhns) reports, “There was a substantial annual economic burden attributed to respiratory syncytial virus diagnoses among high-risk adults, highlighting the need for preventive interventions such as vaccination.” Notably, the economic burden of RSV “among high-risk adults is substantial, suggesting the need to identify preventive interventions to reduce the effects of severe RSV disease.” The findings were published in the Journal of Infectious Diseases.